Evidence map›Paper›PMID 33543710›Full record

SynthesiseLife2021

Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against

Ghulam R Awab, Fahima Aaram, Natsuda Jamornthanyawat, Kanokon Suwannasin, Watcharee Pagornrat, James A Watson, Charles J Woodrow, Arjen M Dondorp, Nicholas Pj Day, Mallika Imwong and 1 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. No G6PD A- (G202A) variant detected amongMalariaWorld journal · 2026
    Article
  11. Article
  12. Human genetic variations conferring resistance to malaria.Journal of translational medicine · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Revealing the secrets of Blue Zones.Frontiers in pharmacology · 2024
    Review
  20. Pathogens (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Ghulam R AwabMahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Fahima AaramKabul Medical University, Kabul, Afghanistan.
Natsuda JamornthanyawatDepartment of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Kanokon SuwannasinDepartment of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Watcharee PagornratDepartment of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
James A WatsonMahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.ORCID 0000-0001-5524-0325
Charles J WoodrowMahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Arjen M DondorpMahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.ORCID 0000-0001-5190-2395
Nicholas Pj DayMahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.ORCID 0000-0003-2309-1171
Mallika ImwongDepartment of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Nicholas J WhiteMahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-1897-1978
Mahidol University · THKabul Medical University · AF

Funding

Wellcome Trust 093956/Z/10/ZWellcome Trust 107548/Z/15/ZWellcome Trust 107548Z/15/Z
6 · The paper itself

Abstract

X-linked glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy. The severe Mediterranean variant (G6PD Med) found across Europe and Asia is thought to confer protection against malaria, but its effect is unclear. We fitted a Bayesian statistical model to observed G6PD Med allele frequencies in 999 Pashtun patients presenting with acute

Indexed as

AfghanistanFemaleGlucosephosphate Dehydrogenase DeficiencyHumansMalaria, VivaxMaleenzymopathyepidemiologyG6PDglobal healthglucose-6-phosphate dehydrogenase deficiencymalariaPlasmodium vivaxprimaquine

Identifiers

PMID33543710
PMCPMC7884069
OpenAlexW3127924688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.